Mathieu Trudel Selected Research

Neurofibromatosis 2 (Neurofibromatosis Type II)

1/2023	Hearing Rehabilitation in Patients With Neurofibromatosis Type 2: The Quebec's Experience With Auditory Implants.
1/2022	Cochlear Implantation in Neurofibromatosis Type 2: Experience From the UK Neurofibromatosis Type 2 Service.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mathieu Trudel Research Topics

Disease

2	Neurofibromatosis 2 (Neurofibromatosis Type II) 01/2023 - 01/2022
1	Vertigo (Positional Vertigo) 02/2024
1	Acoustic Neuroma (Acoustic Neurinoma) 02/2024
1	Sensorineural Hearing Loss 01/2022
1	Pain (Aches) 04/2016
1	Head and Neck Neoplasms (Head and Neck Cancer) 04/2016
1	Carcinoma (Carcinomatosis) 04/2016
1	Nausea 04/2016

Drug/Important Bio-Agent (IBA)

1	AntiemeticsIBA 02/2024
1	Gentamicins (Gentamicin)FDA LinkGeneric 02/2024
1	nabilone (Cesamet)FDA Link 04/2016

Therapy/Procedure

2	Cochlear Implants (Cochlear Implant) 01/2023 - 01/2022
1	Preoperative Exercise 02/2024
1	Exercise Therapy (Therapy, Exercise) 02/2024
1	Length of Stay 02/2024
1	Auditory Brain Stem Implants (Auditory Brainstem Implants) 01/2023
1	Electrodes (Electrode) 01/2022
1	Cochlear Implantation 01/2022
1	Radiotherapy 04/2016